Dopamine Transporter Imaging in Neurological Practice Web cast
September 22, 2006 – London, United Kingdom
Workshop Description
This workshop is intended to introduce participants to the potential of dopamine transporter single photon emission computed tomography (SPECT) imaging in neurological practice and to help answer some of the questions posed by clinicans, researchers, managers, and patients about the appropriate use of dopamine transporter imaging. It aims to present a balanced view of dopamine transporter imaging studies, still in their infancy and perhaps subject to intrinsic variabilities different from, but not necessarily better than, available clinical measures. The scope of information to be presented and discussed has been chosen not only to identify the potential usefulness of dopamine transporter imaging in neurological practice, but also to guard against indiscriminate and injudicious use of dopamine transporter imaging, or erroneous interpretation of findings.
Target Audience
This online activity is recommended for specialists or trainees in Movement Disorders and general neurologists.
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Describe how dopamine transporter imaging is performed and discuss the science underlying the procedure;
- Discuss the interpretation of dopamine transporter images;
- List the diseases/symptoms for which dopamine transporter imaging may be an appropriate investigative tool;
- Explain how patients suitable for this procedure would be identified;
- Discuss the current uses, potential future uses, and limitations of dopamine transporter imaging in neurological clinical practice and research applications.
MDS Educational Disclaimer
Information presented in this activity, as well as publications, technologies, products, and/or services discussed are intended to inform participants about the knowledge, techniques and experiences of physicians who are willing to share such information with colleagues. A diversity of opinions exists in the medical field, and the views of the workshop’s faculty are offered solely for educational purposes. Faculty members’ views do not represent those of MDS nor do they constitute endorsement by MDS. MDS disclaims any and all liability for all claims which may result from the use of information, publications, products, and/or services discussed in this activity.
MDS Content Ownership Statement
The content of this Educational Activity has been generated from the Dopamine Transporter Imaging in Neurological Practice Workshop, held in London, United Kingdom on September 22, 2006, and is the property of The Movement Disorder Society. No part of this material may be reproduced in any form or by any means without the prior written permission of The Movement Disorder Society.
Acknowledgement
The MDS-ES Dopamine Transporter Imaging in Neurological Practice workshop is supported in part by an unrestricted educational grant from GE Healthcare. Although industry support is received, all programs are developed and implemented solely by the Course Planning Committee overseeing this workshop as well as the International Secretariat. Industry supporters sign a letter of agreement stating that they will not influence the faculty or directors and agree specifically to having no direct control or input. MDS uses grant funds to support and enhance existing as well as new programs.
This web cast was also made possible by an educational grant from GE Healthcare.
Evaluations
Please take time to complete the evaluation at the end of this activity. Your input and comments are essential in planning future educational programs for MDS.